← All organizations
European Commission
GovernmentWebsite ↗
Also known as: EurocanPlatform | Eurocan Platform | European Commission | European commission for humanitarian office | European Commission -FP7-Health-2013-Innovation-1 | European Commission (funder) | European Commission H2020 program | Horizon 2020 - European Commission | Innovative Medicines Initiative | Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1998Last known activity
Aug 5, 2024
Timeline
1950s
- Jan 16, 1958
European Commission— Founded
Drugs by trial phase (150 distinct, 115 trials)
Phase 4 (17 own, 0 via acquisition)
- mercaptopurine
- diphtheria, tetanus and whole cell pertussis vaccine
- prednisone
- empagliflozin
- fosfomycin
- insulin glargine
- naltrexone
- adalimumab
- inactivated influenza vaccine
- meropenem
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- sodium bicarbonate
- nitrofurantoin
- sodium chloride
- azathioprine
- +2 more
Phase 3 (36 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (29 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- alpha-Mannosidosis
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Arthritis
- Arthritis, Rheumatoid
- Bacterial Infections
- Bronchiectasis
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Chronic Pain
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Common Cold
- Communicable Diseases
- Coronary Artery Disease
- Crohn Disease
- Cystic Fibrosis
- Cystitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disease Progression
- Fallopian Tube Neoplasms
- Fibrosis
- Graft vs Host Disease
- Gram-Negative Bacterial Infections
- Graves Disease
- Heart Failure
- Hemoglobinopathies
- Hemorrhagic Fever, Ebola
- Hepatitis
- Hepatitis A
- Hepatitis C
- HIV Infections
- Hypertension
- Hypertrophy
- Hypertrophy, Left Ventricular
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Influenza, Human
- Influenza in Birds
- Intraabdominal Infections
- Iron Overload
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Malaria
- Malaria, Falciparum
- Mannosidase Deficiency Diseases
- Meningitis
- Motor Neuron Disease
- Multiple Myeloma
- Multiple Organ Failure
- Myocardial Infarction
- Myositis Ossificans
- Neonatal Sepsis
- Neoplasms, Plasma Cell
- Neuralgia
- Neuralgia, Postherpetic
- Osteosarcoma
- Ovarian Neoplasms
- Parkinson Disease
- Peripheral Nerve Injuries
- Pneumonia
- Pneumonia, Bacterial
- Pneumonia, Ventilator-Associated
- Polyneuropathies
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Infections
- Retinal Diseases
- Sarcoma
- Sarcoma, Ewing
- Sclerosis
- Sepsis
- Spinal Cord Injuries
- Stroke
- Strongyloidiasis
- Tuberculosis
- Tuberculosis, Pulmonary
- Ulcer
- Urinary Tract Infections
- Virus Diseases
- Whooping Cough
- Wounds and Injuries
Recent trials (50)
- NCT06476184CollaboratorPhase 3Aug 5, 2024
- NCT06296082CollaboratorPhase 2/Phase 3Jul 1, 2024
- NCT06364631CollaboratorPhase 3Apr 12, 2024
- NCT05847517CollaboratorPhase 3Nov 30, 2023
- NCT05780151CollaboratorPhase 4Jun 30, 2023
- NCT05748405CollaboratorPhase 1/Phase 2Dec 15, 2022
- NCT05621083CollaboratorN/ANov 30, 2022
- NCT05608187CollaboratorPhase 2Sep 26, 2022
- NCT06825156CollaboratorPhase 4Mar 3, 2022
- NCT04979052CollaboratorPhase 2Dec 31, 2021
- NCT05160766CollaboratorPhase 2Nov 8, 2021
- NCT05402527CollaboratorN/ANov 8, 2021
- NCT05396963CollaboratorN/ANov 1, 2021
- NCT05170737CollaboratorPhase 1Oct 1, 2021
- NCT04711356CollaboratorPhase 2Jul 8, 2021
Details
- Founded
- Brussels, BE Jan 16, 1958
- Last known activity
- Aug 5, 2024